IMMUTEP LIMITED - Announcements

Market Cap $428.5M Add to my watchlist

Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IMM	Appendix 3B		27/12/13	434.24KB	Share
IMM	Prima Analyst Briefing Document		09/12/13	1.71MB	Share
IMM	Poster for Society for Immunotherapy of Cancer Meeting		26/11/13	810.23KB	Share
IMM	Presentation slides for Regenerative Medicine Meeting		26/11/13	2.63MB	Share
IMM	Expert panel to discuss CVac clinical trial data		26/11/13	232.08KB	Share
IMM	Appendix 3Z		22/11/13	195.11KB	Share
IMM	Change of Director's Interest Notice		21/11/13	333.84KB	Share
IMM	Prima presents at Regenerative Medicine Meeting		20/11/13	225.06KB	Share
IMM	Change of Director's Interest Notice		19/11/13	399.57KB	Share
IMM	Results of Meeting		15/11/13	160.84KB	Share
IMM	2013 AGM Chairman Address		15/11/13	202.06KB	Share
IMM	2013 AGM CEO presentation slides		15/11/13	1.16MB	Share
IMM	2013 AGM CEO Address	PRICE SENSITIVE	15/11/13	233.96KB	Share
IMM	Update on CVac Clinical Development Program	PRICE SENSITIVE	11/11/13	208.28KB	Share
IMM	First Quarter Conference Call Transcript		11/11/13	239.75KB	Share
IMM	Supplemental Information for Quarterly Conference Call		07/11/13	685.02KB	Share
IMM	Prima and Neopharm enter into licence for CVac in Israel	PRICE SENSITIVE	06/11/13	211.84KB	Share
IMM	First Quarter Highlights & Conference Call		01/11/13	445.4KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/13	384.42KB	Share
IMM	Annual Report on Form 20-F filed with SEC		31/10/13	1.25MB	Share
IMM	Annual Report to shareholders		14/10/13	952.71KB	Share
IMM	Notice of Annual General Meeting/Proxy Form		14/10/13	633.71KB	Share
IMM	Change of Director's Interest Notice		10/10/13	333.65KB	Share
IMM	Change of Director's Interest Notice		09/10/13	334.16KB	Share
IMM	Change of Director's Interest Notice		03/10/13	334.25KB	Share
IMM	Transcript of Management Presentation on CVac Phase 2 Trial		03/10/13	127KB	Share
IMM	Supplemental information to management presentation		01/10/13	765.67KB	Share
IMM	Management Presentation of CVac Phase 2 Trial Results		01/10/13	207.74KB	Share
IMM	Top-line Analysis of CVac Phase 2 Trial	PRICE SENSITIVE	18/09/13	235.78KB	Share
IMM	Prima to present at 1st Global Life Sciences Conference		11/09/13	205.95KB	Share
IMM	Prima to present to Society for Immunotherapy of Cancer		04/09/13	92.03KB	Share
IMM	Appendix 4E & 2013 Full Year Statutory Accounts	PRICE SENSITIVE	30/08/13	6.87MB	Share
IMM	Prima Files US Shelf Registration Statement		29/08/13	645.72KB	Share
IMM	Prima to Present at Global Investment Conference		21/08/13	89.97KB	Share
IMM	Cleansing Notice & Appendix 3B		15/08/13	547.23KB	Share
IMM	Approval received to start CANVAS clinical trials in Korea	PRICE SENSITIVE	14/08/13	211.86KB	Share
IMM	Cleansing Notice & Appendix 3B		08/08/13	546.44KB	Share
IMM	Fourth Quarter Conference Call Transcript		08/08/13	212.83KB	Share
IMM	Supplemental Information for Quarterly Conference Call		06/08/13	582.83KB	Share
IMM	Fourth Quarter Highlights and Conference Call		26/07/13	335.57KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	26/07/13	384.51KB	Share
IMM	Cleansing Notice & Appendix 3B		19/07/13	547.46KB	Share
IMM	Response to ASX Price Query	PRICE SENSITIVE	11/07/13	111.39KB	Share
IMM	Change of Director's Interest Notice		05/07/13	408.65KB	Share
IMM	New clinical trial sites activated in Europe for CANVAS	PRICE SENSITIVE	04/07/13	175.35KB	Share
IMM	New Phase 2 Clinical Programs for CVac	PRICE SENSITIVE	25/06/13	232.53KB	Share
IMM	Trading Halt Request		24/06/13	263KB	Share
IMM	Trading Halt	PRICE SENSITIVE	24/06/13	26.26KB	Share
IMM	Change of Director's Interest Notice		19/06/13	282.67KB	Share
IMM	Change of Director's Interest Notice		19/06/13	332.11KB	Share
IMM	Change of Director's Interest Notice		19/06/13	322.9KB	Share
IMM	CAN-003 to be presented at European Cancer Congress		19/06/13	226.08KB	Share
IMM	Options - Top 20 and distribution schedule		18/06/13	308.12KB	Share
IMM	Completion of Entitlement Offer		13/06/13	382.81KB	Share
IMM	Prima Newsletter		13/06/13	418.78KB	Share
IMM	Change of Director's Interest Notice		27/05/13	333.85KB	Share
IMM	Mailing of Prospectus and Entitlement and Acceptance Form		24/05/13	468.41KB	Share
IMM	Prima to present at Marcum LLP Microcap Conference		20/05/13	222.65KB	Share
IMM	Change of Director's Interest Notice		20/05/13	323.46KB	Share
IMM	Change of Director's Interest Notice		20/05/13	323.64KB	Share
IMM	Change of Director's Interest Notice		20/05/13	333.73KB	Share
IMM	Change of Director's Interest Notice		20/05/13	281.07KB	Share
IMM	Change of Director's Interest Notice		20/05/13	322.83KB	Share
IMM	Cleansing Statement & Appendix 3B	PRICE SENSITIVE	17/05/13	151.74KB	Share
IMM	Results of Meeting		16/05/13	197.09KB	Share
IMM	EGM 2013 Chairman's Address		16/05/13	279.07KB	Share
IMM	Completion of SPP	PRICE SENSITIVE	15/05/13	395.37KB	Share
IMM	Entitlement Offer Letter to Shareholders		14/05/13	289.03KB	Share
IMM	Entitlement Offer Prospectus & Appendix 3B	PRICE SENSITIVE	13/05/13	878.25KB	Share
IMM	Appendix 3X		08/05/13	213.49KB	Share
IMM	Director Appointment		08/05/13	231.65KB	Share
IMM	Prima Newsletter		03/05/13	320.19KB	Share
IMM	Prima Presentation at ISCT Annual Meeting		24/04/13	679.07KB	Share
IMM	Supplemental Information for Quarterly Conference Call		24/04/13	581.94KB	Share
IMM	PRIMA BIOMED UPDATES CLINICAL LEADERSHIP TEAM		24/04/13	226.24KB	Share
IMM	PRIMA BIOMED QUARTERLY RESULTS AND CONFERENCE CALL	PRICE SENSITIVE	19/04/13	488.11KB	Share
IMM	JAPANESE PATENT GRANTED FOR CVAC	PRICE SENSITIVE	17/04/13	226.86KB	Share
IMM	Change of Director's Interest Notice		12/04/13	333.91KB	Share
IMM	Change of Director's Interest Notice		11/04/13	328.3KB	Share
IMM	Notice under ASIC CO 09/425		11/04/13	68.88KB	Share
IMM	Notice of Extraordinary General Meeting/Proxy Form		11/04/13	541.43KB	Share
IMM	Share Purchase Plan Offer Documents		11/04/13	445.05KB	Share
IMM	Change of Director's Interest Notice		10/04/13	322.99KB	Share
IMM	Share Purchase Plan Update	PRICE SENSITIVE	09/04/13	455.41KB	Share
IMM	Change in Senior Management		28/03/13	215.82KB	Share
IMM	3.8 MILLION EURO GRANT TO SUPPORT CVAC DEVELOPMENT	PRICE SENSITIVE	20/03/13	217.75KB	Share
IMM	Prima BioMed to Present at ISBioTech Annual Meeting		11/03/13	329.05KB	Share
IMM	Prima BioMed Conference Call Transcript		08/03/13	219.14KB	Share
IMM	Supplemental Information for Prima BioMed Conference Call		06/03/13	788.8KB	Share
IMM	Prima Biomed Conference Call		05/03/13	210.8KB	Share
IMM	Prima Biomed commences CANVAS Clinical Trial in Europe	PRICE SENSITIVE	28/02/13	217.49KB	Share
IMM	Prima Newsletter		26/02/13	574.27KB	Share
IMM	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/13	1.98MB	Share
IMM	Appendix 3B		21/02/13	280.87KB	Share
IMM	Prima receives $1.4m R&D Tax Incentive rebate	PRICE SENSITIVE	06/02/13	241.08KB	Share
IMM	Investor Presentation February 2013		04/02/13	1.21MB	Share
IMM	Prima presents at ISCT annual meeting		04/02/13	229.09KB	Share
IMM	Prima to present at BIO CEO & Investor Conference		29/01/13	213.1KB	Share
IMM	Prima BioMed to host investor days in Australia		24/01/13	214.1KB	Share
IMM	Appendix 4C - quarterly	PRICE SENSITIVE	23/01/13	517.75KB	Share

IMMAppendix 3B
27/12/13		434.24KB	Share
IMMPrima Analyst Briefing Document
09/12/13		1.71MB	Share
IMMPoster for Society for Immunotherapy of Cancer Meeting
26/11/13		810.23KB	Share
IMMPresentation slides for Regenerative Medicine Meeting
26/11/13		2.63MB	Share
IMMExpert panel to discuss CVac clinical trial data
26/11/13		232.08KB	Share
IMMAppendix 3Z
22/11/13		195.11KB	Share
IMMChange of Director's Interest Notice
21/11/13		333.84KB	Share
IMMPrima presents at Regenerative Medicine Meeting
20/11/13		225.06KB	Share
IMMChange of Director's Interest Notice
19/11/13		399.57KB	Share
IMMResults of Meeting
15/11/13		160.84KB	Share
IMM2013 AGM Chairman Address
15/11/13		202.06KB	Share
IMM2013 AGM CEO presentation slides
15/11/13		1.16MB	Share
IMM2013 AGM CEO Address
15/11/13	PRICE SENSITIVE	233.96KB	Share
IMMUpdate on CVac Clinical Development Program
11/11/13	PRICE SENSITIVE	208.28KB	Share
IMMFirst Quarter Conference Call Transcript
11/11/13		239.75KB	Share
IMMSupplemental Information for Quarterly Conference Call
07/11/13		685.02KB	Share
IMMPrima and Neopharm enter into licence for CVac in Israel
06/11/13	PRICE SENSITIVE	211.84KB	Share
IMMFirst Quarter Highlights & Conference Call
01/11/13		445.4KB	Share
IMMAppendix 4C - quarterly
31/10/13	PRICE SENSITIVE	384.42KB	Share
IMMAnnual Report on Form 20-F filed with SEC
31/10/13		1.25MB	Share
IMMAnnual Report to shareholders
14/10/13		952.71KB	Share
IMMNotice of Annual General Meeting/Proxy Form
14/10/13		633.71KB	Share
IMMChange of Director's Interest Notice
10/10/13		333.65KB	Share
IMMChange of Director's Interest Notice
09/10/13		334.16KB	Share
IMMChange of Director's Interest Notice
03/10/13		334.25KB	Share
IMMTranscript of Management Presentation on CVac Phase 2 Trial
03/10/13		127KB	Share
IMMSupplemental information to management presentation
01/10/13		765.67KB	Share
IMMManagement Presentation of CVac Phase 2 Trial Results
01/10/13		207.74KB	Share
IMMTop-line Analysis of CVac Phase 2 Trial
18/09/13	PRICE SENSITIVE	235.78KB	Share
IMMPrima to present at 1st Global Life Sciences Conference
11/09/13		205.95KB	Share
IMMPrima to present to Society for Immunotherapy of Cancer
04/09/13		92.03KB	Share
IMMAppendix 4E & 2013 Full Year Statutory Accounts
30/08/13	PRICE SENSITIVE	6.87MB	Share
IMMPrima Files US Shelf Registration Statement
29/08/13		645.72KB	Share
IMMPrima to Present at Global Investment Conference
21/08/13		89.97KB	Share
IMMCleansing Notice & Appendix 3B
15/08/13		547.23KB	Share
IMMApproval received to start CANVAS clinical trials in Korea
14/08/13	PRICE SENSITIVE	211.86KB	Share
IMMCleansing Notice & Appendix 3B
08/08/13		546.44KB	Share
IMMFourth Quarter Conference Call Transcript
08/08/13		212.83KB	Share
IMMSupplemental Information for Quarterly Conference Call
06/08/13		582.83KB	Share
IMMFourth Quarter Highlights and Conference Call
26/07/13		335.57KB	Share
IMMAppendix 4C - quarterly
26/07/13	PRICE SENSITIVE	384.51KB	Share
IMMCleansing Notice & Appendix 3B
19/07/13		547.46KB	Share
IMMResponse to ASX Price Query
11/07/13	PRICE SENSITIVE	111.39KB	Share
IMMChange of Director's Interest Notice
05/07/13		408.65KB	Share
IMMNew clinical trial sites activated in Europe for CANVAS
04/07/13	PRICE SENSITIVE	175.35KB	Share
IMMNew Phase 2 Clinical Programs for CVac
25/06/13	PRICE SENSITIVE	232.53KB	Share
IMMTrading Halt Request
24/06/13		263KB	Share
IMMTrading Halt
24/06/13	PRICE SENSITIVE	26.26KB	Share
IMMChange of Director's Interest Notice
19/06/13		282.67KB	Share
IMMChange of Director's Interest Notice
19/06/13		332.11KB	Share
IMMChange of Director's Interest Notice
19/06/13		322.9KB	Share
IMMCAN-003 to be presented at European Cancer Congress
19/06/13		226.08KB	Share
IMMOptions - Top 20 and distribution schedule
18/06/13		308.12KB	Share
IMMCompletion of Entitlement Offer
13/06/13		382.81KB	Share
IMMPrima Newsletter
13/06/13		418.78KB	Share
IMMChange of Director's Interest Notice
27/05/13		333.85KB	Share
IMMMailing of Prospectus and Entitlement and Acceptance Form
24/05/13		468.41KB	Share
IMMPrima to present at Marcum LLP Microcap Conference
20/05/13		222.65KB	Share
IMMChange of Director's Interest Notice
20/05/13		323.46KB	Share
IMMChange of Director's Interest Notice
20/05/13		323.64KB	Share
IMMChange of Director's Interest Notice
20/05/13		333.73KB	Share
IMMChange of Director's Interest Notice
20/05/13		281.07KB	Share
IMMChange of Director's Interest Notice
20/05/13		322.83KB	Share
IMMCleansing Statement & Appendix 3B
17/05/13	PRICE SENSITIVE	151.74KB	Share
IMMResults of Meeting
16/05/13		197.09KB	Share
IMMEGM 2013 Chairman's Address
16/05/13		279.07KB	Share
IMMCompletion of SPP
15/05/13	PRICE SENSITIVE	395.37KB	Share
IMMEntitlement Offer Letter to Shareholders
14/05/13		289.03KB	Share
IMMEntitlement Offer Prospectus & Appendix 3B
13/05/13	PRICE SENSITIVE	878.25KB	Share
IMMAppendix 3X
08/05/13		213.49KB	Share
IMMDirector Appointment
08/05/13		231.65KB	Share
IMMPrima Newsletter
03/05/13		320.19KB	Share
IMMPrima Presentation at ISCT Annual Meeting
24/04/13		679.07KB	Share
IMMSupplemental Information for Quarterly Conference Call
24/04/13		581.94KB	Share
IMMPRIMA BIOMED UPDATES CLINICAL LEADERSHIP TEAM
24/04/13		226.24KB	Share
IMMPRIMA BIOMED QUARTERLY RESULTS AND CONFERENCE CALL
19/04/13	PRICE SENSITIVE	488.11KB	Share
IMMJAPANESE PATENT GRANTED FOR CVAC
17/04/13	PRICE SENSITIVE	226.86KB	Share
IMMChange of Director's Interest Notice
12/04/13		333.91KB	Share
IMMChange of Director's Interest Notice
11/04/13		328.3KB	Share
IMMNotice under ASIC CO 09/425
11/04/13		68.88KB	Share
IMMNotice of Extraordinary General Meeting/Proxy Form
11/04/13		541.43KB	Share
IMMShare Purchase Plan Offer Documents
11/04/13		445.05KB	Share
IMMChange of Director's Interest Notice
10/04/13		322.99KB	Share
IMMShare Purchase Plan Update
09/04/13	PRICE SENSITIVE	455.41KB	Share
IMMChange in Senior Management
28/03/13		215.82KB	Share
IMM3.8 MILLION EURO GRANT TO SUPPORT CVAC DEVELOPMENT
20/03/13	PRICE SENSITIVE	217.75KB	Share
IMMPrima BioMed to Present at ISBioTech Annual Meeting
11/03/13		329.05KB	Share
IMMPrima BioMed Conference Call Transcript
08/03/13		219.14KB	Share
IMMSupplemental Information for Prima BioMed Conference Call
06/03/13		788.8KB	Share
IMMPrima Biomed Conference Call
05/03/13		210.8KB	Share
IMMPrima Biomed commences CANVAS Clinical Trial in Europe
28/02/13	PRICE SENSITIVE	217.49KB	Share
IMMPrima Newsletter
26/02/13		574.27KB	Share
IMMHalf Yearly Report and Accounts
22/02/13	PRICE SENSITIVE	1.98MB	Share
IMMAppendix 3B
21/02/13		280.87KB	Share
IMMPrima receives $1.4m R&D Tax Incentive rebate
06/02/13	PRICE SENSITIVE	241.08KB	Share
IMMInvestor Presentation February 2013
04/02/13		1.21MB	Share
IMMPrima presents at ISCT annual meeting
04/02/13		229.09KB	Share
IMMPrima to present at BIO CEO & Investor Conference
29/01/13		213.1KB	Share
IMMPrima BioMed to host investor days in Australia
24/01/13		214.1KB	Share
IMMAppendix 4C - quarterly
23/01/13	PRICE SENSITIVE	517.75KB	Share

REFRESH

First 8 9 10 11 12

(20min delay)
Last 29.5¢		Change 0.000(0.00%)		Mkt cap ! $428.5M

Open	High	Low	Value	Volume
30.0¢	30.5¢	29.0¢	$732.3K	2.454M

Buyers (Bids)

No.	Vol.	Price($)
2	113261	29.5¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	169614	3

View Market Depth

No.	Vol.	Price($)
1	13261	0.295
16	654614	0.290
21	379613	0.285
29	1373806	0.280
6	191364	0.275

Price($)	Vol.	No.
0.305	169614	3
0.310	180851	7
0.315	368109	3
0.320	139107	4
0.325	10000	1

Last trade - 16.10pm 22/07/2024 (20 minute delay)


Last 30.0¢		Change 0.000 ( 1.56 %)
Open	High	Low	Volume
30.5¢	30.5¢	29.5¢	811598
Last updated 15.59pm 22/07/2024 ?

IMM (ASX) Chart

IMMUTEP LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available